BSE filing, NSE: DPABHUSHAN. Summary written from the filing by ALFA Finder's alert engine.
D P Abhushan Ltd: key numbers
- Share price
- ₹2,048.50
- Market cap
- ₹4,676 Cr
- Revenue (annual)
- ₹4,065 Cr
- Net profit (annual)
- ₹211.8 Cr
- P/E (TTM)
- 19.5×Sector 49.0×
- Promoter holding
- 74.89%+0.00% QoQ
- FII holding
- 0.45%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from D P Abhushan Ltd
All →D P Abhushan Preferential Issue
D.P. Abhushan replaced two proposed allottees in its ₹123.90 crore preferential equity issue via an EoGM notice corrigendum. Total consideration is unchanged; approvals remain pending.
- Value
- ₹123.9 Cr
D P Abhushan Other Announcement
D.P. Abhushan Ltd filed its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended September 30, 2026.
D P Abhushan Other Announcement
D. P. Abhushan Limited filed a certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018, confirming that the regulation is not applicable as all shares are dematerialised.
D P Abhushan Annual General Meeting
D. P. Abhushan Limited has issued a notice for an Extra-ordinary General Meeting (EGM) to be held on October 29, 2026, to seek shareholder approval for preferential issuance.
D P Abhushan Annual General Meeting
D. P. Abhushan Limited announced an Extra-ordinary General Meeting on October 29, 2026, to approve a preferential fund raise of Rs. 558.01 Crore via shares and warrants.
- Value
- ₹558.0 Cr
D P Abhushan Fund Raise of ₹558 Cr
D.P. Abhushan Ltd's board approved a preferential issue of equity shares and warrants, aiming to raise a total of approximately ₹558.01 Crore.
- Value
- ₹558.0 Cr
Other board meeting date announcements
All →Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.
Salzer Electronics Board Meeting Date
Salzer Electronics Limited intimated a board meeting on 12 November 2026 to consider unaudited standalone and consolidated half-yearly results for September 2026. The trading window closes from 1 October to 14 November 2026.
Ekansh Concepts Board Meeting Date
Ekansh Concepts has scheduled a board meeting for November 5, 2026, to consider Q2 and H1 FY27 un-audited financial results. No figures are disclosed.